Infection of inbred mouse strains with Leishmania major has become an exceptional model for CD4 plus T helper subset development in vivo. Whereas most strains of mice develop protective type 1 immune responses, BALB/c mice develop aberrant type 2 responses and suffer disseminated infection. The association of type 1 and type 2 immunity with numerous human infectious and autoimmune diseases suggests that understanding the genetic differences underlying the differentiation of these effector T cell populations would be of much importance. We have identified a dominant parasite antigen, designated LACK, that is the focus of the early CD4 plus T cell response in infected mice. The T cell response is oligoclonal, as manifest by overwhelming usage of V beta 4/V alpha 8 heterodimeric T cell receptors (TCR) by LACK-reactive cells. To begin to understand the role of this dominant antigen in disease susceptibility, we created TCR transgenic mice that expressed a LACK- reactive clonotypic TCR, and bred these mice onto both susceptible BALB/c and resistant B10.D2 strains. CD4 plus transgenic T cells from BALB, but not B10, could be shown to produce IL-4 after stimulation with LACK or parasite antigens in vitro and in vivo. As an artifact of transgenesis, however, CD4-CD8 minus T cells that expressed the TCR transgene were also evident in both the thymus and periphery of these mice. In contrast to CD4 plus cells, the doubt-negative (DN) cells were unable to produce or respond to IL-4. Experiments in mice with disruption of the CD4 gene also demonstrated inefficient development of Th2 cells, suggesting a potential role for the CD4 coreceptor in Th subset differentiation. Cells from these mice will be used, first, to examine the critical role of LACK-reactive cells in defining disease susceptibility in BALB/c mice, and second, to characterize the failure of the CD4 minus cells to complete Th2 development. Methods for targeting LACK-reactive precursors for deletion or tolerance will be used to accomplish the first specific aim, and analysis of the TCR and its signaling capacity will be analyzed in comparing CD4 plus and CD4 minus populations in the second aim. Together, these studies will suggest novel paradigms for disease susceptibility by establishing that selection of a very discrete pool of precursor T cells underlies susceptibility to highly complex infectious diseases. Further, targeting this pool by either understanding its fine specificity or the requirements for Th development can overcome genetic tendencies and provide protection from otherwise fatal infection.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI030663-09
Application #
2855985
Study Section
Tropical Medicine and Parasitology Study Section (TMP)
Program Officer
James, Stephanie
Project Start
1991-01-01
Project End
2002-12-31
Budget Start
1999-01-01
Budget End
1999-12-31
Support Year
9
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
073133571
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Nusse, Ysbrand M; Savage, Adam K; Marangoni, Pauline et al. (2018) Parasitic helminths induce fetal-like reversion in the intestinal stem cell niche. Nature 559:109-113
Ricardo-Gonzalez, Roberto R; Van Dyken, Steven J; Schneider, Christoph et al. (2018) Tissue signals imprint ILC2 identity with anticipatory function. Nat Immunol 19:1093-1099
Schneider, Christoph; O'Leary, Claire E; von Moltke, Jakob et al. (2018) A Metabolite-Triggered Tuft Cell-ILC2 Circuit Drives Small Intestinal Remodeling. Cell 174:271-284.e14
Van Dyken, Steven J; Liang, Hong-Erh; Naikawadi, Ram P et al. (2017) Spontaneous Chitin Accumulation in Airways and Age-Related Fibrotic Lung Disease. Cell 169:497-509.e13
Savage, Adam K; Liang, Hong-Erh; Locksley, Richard M (2017) The Development of Steady-State Activation Hubs between Adult LTi ILC3s and Primed Macrophages in Small Intestine. J Immunol 199:1912-1922
von Moltke, Jakob; O'Leary, Claire E; Barrett, Nora A et al. (2017) Leukotrienes provide an NFAT-dependent signal that synergizes with IL-33 to activate ILC2s. J Exp Med 214:27-37
Van Dyken, Steven J; Nussbaum, Jesse C; Lee, Jinwoo et al. (2016) A tissue checkpoint regulates type 2 immunity. Nat Immunol 17:1381-1387
von Moltke, Jakob; Ji, Ming; Liang, Hong-Erh et al. (2016) Tuft-cell-derived IL-25 regulates an intestinal ILC2-epithelial response circuit. Nature 529:221-5
Mohapatra, A; Van Dyken, S J; Schneider, C et al. (2016) Group 2 innate lymphoid cells utilize the IRF4-IL-9 module to coordinate epithelial cell maintenance of lung homeostasis. Mucosal Immunol 9:275-86
Lee, Min-Woo; Odegaard, Justin I; Mukundan, Lata et al. (2015) Activated type 2 innate lymphoid cells regulate beige fat biogenesis. Cell 160:74-87

Showing the most recent 10 out of 88 publications